Clinical Data Innovation In A Non-EDC Centric World
Nov 1, 2023
auto_awesome
Patrick Nadolny, Global Head of Clinical Data Management at Sanofi, discusses the future of EDC, new programs at Sanofi, and the need for a patient-driven trial model. They explore the evolving landscape of clinical data management, the impact and challenges of data management in clinical trials, and the importance of simplifying processes and partnering with technology providers for solutions. They also emphasize the need for continued experimentation and rethinking strategies in clinical data innovation.
The clinical trials industry is undergoing a transformation with the influx of new data sources, such as medical imaging and genomics, requiring a shift towards effective management and value extraction from diverse data sources.
Regulatory changes and advancements in technology are driving the need for simplified trial designs, operational feasibility, and a focus on patient-driven trials that prioritize individual patient preferences and needs.
Deep dives
Transforming Data Management and Extracting Value from Data
The podcast explores the transformation of data management in the clinical trials industry. The speaker highlights the need for a shift from paper to electronic clinical data capture (EDC) and emphasizes that the transformation goes beyond EDC. The industry is experiencing an inflection point, with the influx of new types of data sources like medical imaging, genomics, and labs. The management of these diverse data sources and the extraction of value from them has become crucial. The speaker also mentions the changing landscape of clinical trials, with a move towards complex protocols, adaptive designs, and a focus on patient-centricity. Moreover, reducing the burden on sites and patients is seen as an important goal, aligning with the idea of patient-driven trials.
Regulatory Changes and Risk-based Approach in Clinical Research
The podcast discusses the role of regulators in advocating for modernizing clinical research. The speaker mentions the risk-based approach introduced by ICHE 602 in 2018, which emphasizes focusing on what matters and reducing risk. The speaker highlights the need to comply with regulations that require a critical focus on data and processes. The speaker cites discussions with regulators, where the burden on sites and patients was addressed, encouraging simplification and operational feasibility in trial design. The speaker also mentions regulations that emphasize quality by design and operational feasibility. The podcast underscores the importance of keeping pace with regulatory changes and technology advancements.
The Act for Patients and Patient-Driven Trials
The podcast explores the concept of the 'act for patients' and its significance in trial design and data management. The speaker emphasizes the need to focus on treating patients as individuals and offering them trial options tailored to their preferences and needs. The objective is to simplify the trial experience, reduce the burden on both patients and sites, and integrate various data sources into an ecosystem that benefits patients and the trial process. The speaker discusses the goal of creating a patient-driven trial environment where patient choices and preferences are respected within the framework of the protocol. The speaker also mentions the challenges of managing data from multiple sources and the importance of data integrity and traceability.
The Future of Data Management and Clinical Trials
The podcast delves into the future of data management in the context of clinical trials. The speaker discusses the importance of volume, velocity, variety, and veracity (the 4 V's of data) in managing clinical trial data. The increasing volume and diversity of data sources require a shift from reactive to proactive data management approaches. The speaker highlights the need to focus on the value of data, ensuring it is collected correctly from the beginning, and adopting predictive algorithms to address missing data and improve data quality. The podcast also touches on the need for collaboration, experimentation, and a mindset shift to embrace new technologies, such as decentralized trial models and AI, in order to optimize data management and drive future advancements in the industry.
Host: Richard Young, Vice President of Strategy, Veeva Vault CDMS
Guest: Patrick Nadolny, Global Head of Clinical Data Management, Sanofi
This week, Richard Young speaks to Patrick Nadolny, global head of clinical data management, Sanofi. In recent years, there’s been an explosion of new data from non-EDC sources like ePRO, imaging, and telemedecine. But, what does that mean for traditional EDC? In this episode, Richard and Patrick discuss the future of EDC – and whether we should retire the term all together. Plus, Patrick discusses new programs at Sanofi including what he calls “EDC-less” trials and a new “Act for Patients” initiative.
Get in touch with us if you would like to contribute to the podcast or share your feedback SDCTpod@veeva.com
Subscribe to State of Digital Clinical Trials, a Veeva podcast, to get new episodes as soon as they are released.
Get the Snipd podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share & Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode